Antigenic peptide, immunogenic composition against schistosomiasis containing the peptide, and uses

WO2025166439A1PCT designated stage Publication Date: 2025-08-14INSTITUTO BUTANTAN
View PDF 4 Cites 0 Cited by

Patent Information

Application Number
PCT/BR2025/050048
Authority / Receiving Office
WO · WO
Patent Type
Applications
Current Assignee / Owner
Priority Date
2025-02-07
Filing Date
2025-02-07
Publication Date
2025-08-14

Smart Images

  • Figure BR2025050048_14082025_PF_FP_ABST
    Figure BR2025050048_14082025_PF_FP_ABST
Patent Text Reader

Abstract

The present invention relates to a new vaccine candidate against schistosomiasis. This vaccine candidate is composed of peptides from different proteins of the parasite Schistosoma mansoni. Additionally, the present invention relates to use of the peptides for preparing a medicament for the prevention and / or treatment of schistosomiasis and to a method for preventing and / or treating schistosomiasis.
Need to check novelty before this filing date? Find Prior Art

Citation Information

Patent Citations

  • Molecular adjuvant

    US20220111065A1

  • CD38 modulated chemotaxis

    US8084035B2

  • Screen of schistosoma mansoni diagnostic antigen and use

    WO2015172706A1

  • BR102018007876A2